Managing Pott's disease, or spinal tuberculosis, involves monitoring the patient for neurological changes and physical deformities, and treating the disease with a combination of chemotherapy, anti-tuberculosis medications and surgery, according to the National Institutes of Health. The patient is at risk of developing antimicrobial drug resistance due to treatment.
Pott's disease occurs outside the lungs in the thoracic and upper lumbar vertebrae in the spine. This condition occurs in less than 1 percent of all tuberculosis cases, according to the National Institutes of Health, or NIH. Neurological deficits occur when the vertebrae compress adjacent neural structures. Experts have observed cases of spinal tuberculosis in 5,000-year-old Egyptian mummies.
Historical treatment of Pott's disease involved placing the patient in a body cast, which decreased weight placed on the affected vertebrae, describes NIH. Other treatments included draining abscesses and posterior spinal fusion
The National Institutes of Health divides Pott's disease patients into two categories: those without neurological complications and those with neurological complications. The agency recommends medical therapy and surgical intervention in only a few select cases of those without neurological complications. It recommends a combination of medical therapy and surgical intervention for those patients who do have neurological complications resulting from Pott's disease.